Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Goldstone

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgery|October 12, 2023
Stratification of Stage II Colon Cancer Using Recurrence Prediction Value: A Multi-institutional International Retrospective StudyShodai Mizuno, Kohei Shigeta, Yujin Kato, et al.
Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Wellcome Open Research|June 8, 2021
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assayMichael D Buck, Enzo Z Poirier, Ana Cardoso, et al.
Science (New York, N.Y.)|April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunityEvangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.
Lancet (London, England)|June 22, 2023
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest LondonChris Bailey, Theo Sanderson, Hermaleigh Townsley, et al.
Nature Biotechnology|June 20, 2020
Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Biotechnology|July 19, 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Annals of Surgery|October 12, 2023
Stratification of Stage II Colon Cancer Using Recurrence Prediction Value: A Multi-institutional International Retrospective StudyShodai Mizuno, Kohei Shigeta, Yujin Kato, et al.
Gastroenterology|July 1, 2021
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation CohortsMichele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Wellcome Open Research|June 8, 2021
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assayMichael D Buck, Enzo Z Poirier, Ana Cardoso, et al.
Science (New York, N.Y.)|April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunityEvangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.
Lancet (London, England)|June 22, 2023
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest LondonChris Bailey, Theo Sanderson, Hermaleigh Townsley, et al.
Nature Biotechnology|June 20, 2020
Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Biotechnology|July 19, 2020
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic centerJim Aitken, Karen Ambrose, Sam Barrell, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Research Square|September 28, 2021
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 4